Filing Details
- Accession Number:
- 0001708138-17-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-05 16:52:38
- Reporting Period:
- 2017-06-01
- Filing Date:
- 2017-06-05
- Accepted Time:
- 2017-06-05 16:52:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-01 | 4,527 | $268.40 | 28,477 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-06-01 | 2,612 | $464.98 | 25,865 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-06-01 | 1,068 | $464.98 | 24,797 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2017-06-01 | 6,017 | $145.70 | 30,814 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-06-01 | 1,885 | $464.98 | 28,929 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-06-01 | 2,167 | $464.98 | 26,762 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $466.33 | 26,662 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $469.83 | 26,562 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $470.49 | 26,462 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $472.10 | 26,362 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $474.82 | 26,262 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $475.33 | 26,162 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $476.52 | 26,062 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 100 | $479.00 | 25,962 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 309 | $480.71 | 25,653 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 695 | $481.64 | 24,958 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 808 | $482.56 | 24,150 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-06-02 | 200 | $483.42 | 23,950 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-01 | 6,017 | $0.00 | 6,017 | $145.70 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-01 | 4,527 | $0.00 | 4,527 | $268.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-02-28 | 2017-12-17 | No | 4 | M | Direct |
0 | 2013-11-10 | 2017-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 10,000 | Indirect | by GRAT |
Common Stock | 5,000 | Indirect | by GRAT |
Common Stock | 5,647 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 309 shares of Company stock on June 2, 2017 at prices ranging from $480.30 to $480.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
- Represents volume-weighted average price of sales of 695 shares of Company stock on June 2, 2017 at prices ranging from $481.25 to $481.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
- Represents volume-weighted average price of sales of 808 shares of Company stock on June 2, 2017 at prices ranging from $482.00 to $482.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on June 2, 2017 at prices ranging from $483.11 to $483.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 2, 2017 at each separate price.